Alliances
Gilead was interested in Cell Design Labs for its technology around bi-specific antigen recognition and its “Throttle” technology.
According to the DoD statement, the contract is for one year with five options to extend the contract for an additional year.
Pfizer acquired China/Asia rights for Cresemba, an antifungal drug developed by Swiss pharma Basilea, in a $226M deal.
The payback was part of a total $3 billion stock repurchasing deal the company initiated on January 27.
The expansion will nearly double its employment.
GlaxoSmithKline will scout for deal opportunities in cancer medicine, as well as immunology, as the drugmaker seeks to rebuild its presence in oncology, its new head of pharmaceuticals told Reuters.
Alexion will use Halozyme’s ENHANZE drug-delivery technology to develop subcutaneous formulations for that company’s portfolio of products.
Amazon didn’t immediately respond to a request for comment.
Under the deal, Carmot will use its lead-identification technology to identify and advance novel drug leads for Parkinson’s disease and other disease areas.
Today, Janssen Biotech announced it had exercised its option to enter into a collaboration deal with Idorsia to jointly develop and market aprocitentan and any derivative compounds.
PRESS RELEASES